Company Search:
Advanced Search
Sponsored Links
argenx SE - ADR Company Snapshot
argenx SE operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx SE with three other companies in this sector in the United States: Neoleukin Therapeutics Inc (2018 sales of $25.00 million of which 100% was Therapeutics For Inflammatory Diseases a), Bioanalytical Systems, Inc. ($26.35 million ), and Applied Genetic Technologies Corp ($24.19 million ).

Sales Analysis. argenx SE reported sales of $25.31 million for the year ending December of 2018. This represents a sharp decrease of 39.0% versus 2017, when the company's sales were $41.48 million. Contributing to the drop in overall sales was the 78.0% decline in Research and Development Service Fees (F, from $7.52 million to $1.66 million. There were also decreases in sales in Upfront Payments (down 55.6% to $10.17 million) . However, these declines were partially offset by the increase in sales of Milestone Payments (up 22.3% to $13.48 million) .
  Stock Performance Chart for argenx SE - ADR
  Stock Data: Recent Stock Performance:
  Current Price (2/21/2020): 161.10
(Figures in U.S. Dollars)
1 Week 0.6%   13 Weeks 11.3%  
4 Weeks 13.6%   52 Weeks 26.9%  
argenx SE - ADR Key Data:
  Ticker: ARGX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 25,311,381
(Year Ending Jan 2019).
Employees: 105
  Currency: U.S. Dollars Market Cap: 6,139,122,600
  Fiscal Yr Ends: December Shares Outstanding: 38,107,527
  Share Type: ADR Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.